EGFRmutated

Latest Posts

New longer-term information from the MARIPOSA examine verify superior outcomes of chemotherapy-free RYBREVANT ®...

Market

RYBREVANT ® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) present robust favorable total survival pattern versus osimertinib in EGFR-mutated superior lung most cancers By Investing.com

‹‹‹First and solely EGFR inhibitor and focused remedy to point out profit in Stage...

Market

TAGRISSO ® (osimertinib) decreased the danger of illness development or demise by 84% in sufferers with unresectable, Stage III EGFR-mutated lung most cancers vs....